Promoter Region of the Human Harvey ras Proto-Oncogene: Similarity to the EGF Receptor Proto-Oncogene Promoter-Reference-Cited by-同舟云学术

Promoter Region of the Human Harvey ras Proto-Oncogene: Similarity to the EGF Receptor Proto-Oncogene Promoter

Published:1985-12-20 Issue:4732 Volume:230 Page:1378-1381
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Ishii Shunsuke¹,Merlino Glenn T.¹,Pastan Ira¹

Affiliation:

1. Laboratory of Molecular Biology, Division of Cancer, Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference38 articles.

1. BENOIST, C, INVIVO SEQUENCE REQUIREMENTS OF THE SV40 EARLY PROMOTER REGION, NATURE 290: 304 (1981).

2. BENOIST, C, OVALBUMIN GENE-SEQUENCE OF PUTATIVE CONTROL REGIONS, NUCLEIC ACIDS RESEARCH 8: 127 (1980).

3. CAPON, D.J., COMPLETE NUCLEOTIDE-SEQUENCES OF THE T24 HUMAN BLADDER-CARCINOMA ONCOGENE AND ITS NORMAL HOMOLOG, NATURE 302: 33 (1983).

4. CAPON, D.J., ACTIVATION OF KI-RAS 2 GENE IN HUMAN-COLON AND LUNG CARCINOMAS BY 2 DIFFERENT POINT MUTATIONS, NATURE 304: 507 (1983).

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G4 DNA in ras genes and its potential in cancer therapy;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2016-04

2. Induction of Ras by SAF ‐1/ MAZ through a feed‐forward loop promotes angiogenesis in breast cancer;Cancer Medicine;2014-11-30

3. HRASis silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property;Nucleic Acids Research;2014-07-10

4. Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells;Biochimica et Biophysica Acta (BBA) - General Subjects;2014-07

5. G4-DNA Formation in the HRAS Promoter and Rational Design of Decoy Oligonucleotides for Cancer Therapy;PLoS ONE;2011-09-08